US Oncology News

Main Category: Cancer / Oncology Also Included In: Dermatology Article Date: 03 Jul 2008 - 1:00 PDT Now that school is out and the first day of summer is upon us, the cancer care experts at Texas Oncology ...

TowerBrook Capital Partners L.P., the New York and London-based private equity firm, announced today that it has signed a definitive agreement to acquire a majority interest in Broadlane, Inc., a leading ...

Jordan Schrader * JSchrade@CITIZEN-TIMES.com * published June 7, 2008 12:15 am Raleigh An Asheville cancer clinic learned this week it has been cleared to fire up long-dormant equipment and start treating its ...

Investor and Media Inquiries Daniel Saks, 310-405-7417 DSaks@abraxisbio.com or AstraZeneca Media Inquiries Only Donna Huang, 302-885-6396 donna.huang@astrazeneca.com Abraxis BioScience, Inc.

US Oncology Holdings, Inc. , the parent company of US Oncology, Inc. , one of the nation's largest cancer services companies, reported revenue of $810.6 million, Adjusted EBITDA of $52.1 million and operating ... via Earth Times

“Ms. Schwalm is an exciting addition to our company. She will be instrumental in driving Eisai's integration of MGI Pharrma and strengthening our presence in the U.S. as a top 20 pharmaceutical company”

Eisai Corp. of North America has appointed Cynthia Schwalm president of Eisai Inc. via Contract Pharma Breaking News

“The NOPR project itself represents a new benchmark for cooperation between CMS and the medical imaging community to help determine the value of new imaging technologies and their impact on patient management”

Main Category: Cancer / Oncology Also Included In: MRI / PET / Ultrasound Article Date: 02 May 2008 US Oncology, which supports one of the nation's largest cancer treatment and research networks representing ... via MediLexicon

“We appreciate his many contributions to US Oncology.”

US Oncology announced today that its Chief Financial Officer, Rick McCook, will resign effective May 2, 2008. via BioSpace

Sign-up Now for a Free Test Drive of a New Sales Prospecting and Leads subscription services. via Houston Business Journal

“I have been privileged to be CEO of US Oncology for 15 years. I have had the opportunity to work closely with Bruce and have tremendous confidence in his ability, dedication and integrity. He is well prepared for his new role.”

Today, the Board of Directors of US Oncology Holdings, Inc. and its wholly owned subsidiary US Oncology, Inc. via BioSpace

“US Oncology's proven ability to contribute to the quality of patient care and enhance practice operations and growth will be invaluable to our team and will help us remain firmly at the leading edge of cancer care.”

Advanced Medical Specialties, a 47-physician oncology practice located in the greater Miami area, today announced that it has entered into an agreement to join US Oncology's network. via Earth Times

Thousands of women with breast cancer could be spared harsh chemotherapy and given a milder treatment that was just as effective, new research has found. via The West Australian

“The investigational Taxotere combination significantly increased the percentage of women living with no signs of cancer at seven years, as compared to the anthracycline combination”

For women with early stage breast cancer who have had surgery, treatment with the investigational chemotherapy combination of Taxotere Injection Concentrate and cyclophosphamide significantly improved overall ... via EMaxHealth

“There is a compelling need for a novel approach to treating this high-risk population.”

BiPar Sciences, Inc., a privately held biopharmaceutical company developing novel cancer therapies, announced it has initiated a Phase 2 study of its lead PARP inhibitor, BSI-201, in patients with ... via MediLexicon

“Treatment options for second-line SCLC are limited and preliminary data from the US-based Phase 2 sensitive SCLC trial indicate that Amrubicin may provide a new option for SCLC patients who desperately need more treatment choices”

Pharmion Corporation released interim findings from its Phase 2 trial of Amrubicin in second-line chemo-sensitive small cell lung cancer . via MediLexicon

US Oncology, which supports one of the nation's largest cancer treatment and research networks representing over 1,100 oncologists nationwide, supports the FDA's label outlining the safe and effective ... via MediLexicon

“We've heard pretty clear comments from the insurance side that they really do not value or trust the oncologist”

As the cancer-treatment landscape changes -- promising longer, healthier lives for patients but with the side effect of astronomical costs -- most health plans and oncologists are locked in a stare-down to see ... via Managed Care

“I was raised to give back to the world, which is why I have dedicated my life to my sister's memory through Susan G. Komen for the Cure and to raising awareness about women's health issues globally”

The ceremonial swearing-in of Ambassador Nancy G. Brinker, founder of Susan G. Komen for the Cure, the world's largest breast cancer organization, as Chief of Protocol was held today at the U.S. Department of ... via Earth Times

“With office space at such a demand, 4,500 feet can go a long way”

Demolition work has begun on the vault of the former West Texas Cancer Center. The work, which began in August, is expected to take 100 workdays. via Odessa American Online